Management of hereditary angioedema in Japan: Focus on icatibant for the treatment of acute attacks

Management of hereditary angioedema in Japan: Focus on icatibant for the treatment of acute attacks

Hereditary angioedema (HAE) is characterized by unpredictable, recurring and painful swelling episodes that can be disabling or even life-threatening. Awareness of HAE has progressively grown worldwide, and options for treatment of acute attacks and prevention of future attacks continue to expand; h...

Full description

Bibliographic Details
Main Authors: Michihiro Hide, Takahiko Horiuchi, Isao Ohsawa, Irmgard Andresen, Atsushi Fukunaga
Format: Article
Language:English
Published: Elsevier 2021-01-01
Series:Allergology International
Subjects:
Bradykinin B2 receptor antagonist
Hereditary angioedema
Icatibant
Japan
Treatment guidelines
Online Access:http://www.sciencedirect.com/science/article/pii/S1323893020301027

Internet

http://www.sciencedirect.com/science/article/pii/S1323893020301027

Similar Items